Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com
Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

Aurobindo Pharma's revenue share 2019 by market

Published by Statista Research Department, Oct 16, 2020
Aurobindo Pharma Limited in India earned the highest share of revenue at 46 percent from its U.S. drug formulations, followed by drug formulations for the European Union in financial year 2019. The company had carved out a niche for itself by developing high quality Active Pharmaceutical Ingredients with a 17 percent share in revenue that year.

Revenue share of Aurobindo Pharma Limited in financial year 2019, by market

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account
$39 $59 per month *
in the first 12 months
View for free
33% discount until December 20th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Additional Information

© Statista 2020

Show source

Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

August 2019

Region

India

Survey time period

FY 2019

Supplementary notes

*ARV refers to of antiretroviral (ARV) drugs used to treat infections by retroviruses, primarily in the management of HIV/AIDS. And API refers to active pharmaceutical ingredients (APIs).
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "GlaxoSmithKline Pharmaceuticals Limited India"

The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu